Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s obesity drug candidate "EPPE" has...
Search results for "obesity treatment"
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, for its next-generation...
Beyond ‘Getting Older’: 3 Major Joint Diseases That Strike in Middle Age
You wake up with stiff, unyielding fingers. Climbing a few flights of stairs leaves your knees throbbing.
Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke
When vision suddenly turns cloudy in one eye and an arm or leg feels unexpectedly weak, many patients immediately fear...
Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound
Popular anti-obesity injections like Wegovy and Mounjaro reduce appetite and prolong feelings of fullness.
As the U.S. Reconsiders Direct-to-Consumer Drug Ads, What Lessons Should We Learn?
During a yearlong stay in the United States, one of the things that struck me most was how easy it is to come across...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Prevention vs. Treatment: Why Cancer Therapy Demands a Completely Different Diet
What makes diabetes particularly dangerous is the risk of severe, systemic complications.
Depressive Symptoms Linked to Higher Fatty Liver Risk in Young Adults
Young adults in South Korea who experience depressive symptoms face roughly twice the risk of developing fatty liver...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.